Skip to content

Reducing Opioid Mortality in Illinois

Justice Community Opioid Innovation Network (JCOIN): Reducing Opioid Mortality in Illinois

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04925427
Acronym
ROMI
Enrollment
1500
Registered
2021-06-14
Start date
2021-08-10
Completion date
2026-08-30
Last updated
2024-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use, Opioid-use Disorder

Brief summary

Reducing Opioid Mortality in Illinois (ROMI) is 5-year research study led by the University of Chicago in partnership with the University of Illinois at Chicago's (UIC) Community Outreach Intervention Projects (COIP), the Illinois Criminal Justice Information Authority (ICJIA) and the American Institutes for Research (AIR). ROMI aims to understand and test strategies for linking individuals with a history of opioid use disorder who are released from Illinois jails and prisons to substance use treatment. ROMI is one of twelve grants awarded by the National Institutes of Health (NIH) as part of the Justice Community Opioid Innovation Network (JCOIN) to support research on quality addiction treatment for opioid use disorder in criminal justice settings nationwide.

Detailed description

This NIDA-funded multi-site randomized control trial (RCT) examines the effectiveness of an established, intensive case management model for study participants who are awaiting release from four jails and two prisons across Illinois. The investigators seek to demonstrate that a unified case management approach can improve treatment engagement and retention among individuals who face high risks of opioid use disorders, overdose, and related harms. The investigators will examine the impact of case management and peer recovery coaching on participants' engagement with treatment and harm reduction interventions. The investigators will also study secondary outcomes including insurance enrollment, re-arrest, use of mental health services, and more. ROMI will enroll at least 300 individuals with opioid disorders in the CMPR group, and at least 300 participants in the naloxone-only across five geographically distinct sites of care. All participants will receive harm reduction resources. The investigators hypothesize that the treatment group will display declines in opioid use, re-arrest, self-reported syringe sharing, and overdose risk behaviors relative to the control groups. The investigators will also examine differences between urban - rural and rural differences in treatment engagement and retention engagement, retention, and downstream outcomes across treatment arms. Aside from demonstrating these treatment impacts, the investigators will guide, document and evaluate ROMI's implementation efforts to ensure consistency across sites across sites and to inform future replication of the model in different settings or for different populations. (Edited 11/27/23 to reflect changes in recruitment from 500 in each treatment arm to 300)

Interventions

BEHAVIORALCase Management and Peer Recovery

A blend between a Critical Time Intervention (CTI) case management model and a peer recovery coaching approach. CORI will employ peer-based case management/recovery coaching and other transitional services (e.g., peer navigation) to provide support and service linkages to medication-assisted treatment (MAT) and harm reduction interventions to reduce subsequent opioid use and related harms.

BEHAVIORALNaloxone-Only

Participants will be trained on naloxone administration, and upon re-entry, they will be given a naloxone kit and information on local resources for harm reduction, SUD treatment, and additional supportive services.

Sponsors

Community Outreach Intervention Projects
CollaboratorUNKNOWN
Cook County Sheriff Office
CollaboratorUNKNOWN
Cook County Health & Hospitals System
CollaboratorOTHER
Lake County Sheriff Office
CollaboratorUNKNOWN
LaSalle County Jail
CollaboratorUNKNOWN
Perfectly Flawed Foundation
CollaboratorUNKNOWN
Jackson County Sheriff Office
CollaboratorUNKNOWN
Illinois Department of Corrections
CollaboratorUNKNOWN
University of Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participants must be at least 18 years old * Reside in designated research site county or zip code * Satisfy criteria for likely OUD based upon nonmedical use of prescription opioids, heroin, or synthetic opioids.

Exclusion criteria

* Participants experiencing cognitive impairments that preclude informed consent. * Reside out of the service area. * Prior enrollment in a parallel JCOIN study.

Design outcomes

Primary

MeasureTime frameDescription
Addiction treatment engagement12 monthsNumber (%) of participants with two or more addiction treatment provider encounters within three months of study enrollment

Secondary

MeasureTime frameDescription
Percent of participant utilizing mental health services90 daysDefined as any mental health utilization within 90 days conditional on CAT-MH diagnostic.
Days of Opioid Use12 monthsA self-reported count 0 to 90 days of using any kind of opioids each quarter, as indicated by the Global Appraisal of Individual Needs (GAIN)assessment tool.
Days of stimulant Use12 monthsA self-reported count 0 to 90 days of using any kind of stimulants each quarter, as indicated by the Global Appraisal of Individual Needs (GAIN)assessment tool.
Opioid Use Disorder (OUD) Symptoms12 monthsA self-reported count of Opioid Use Disorder (OUD) symptoms, again as captured by the GAIN instrument, measuring past month, past 90 days, year, and lifetime. SUD/MH symptoms as captured by the CAT-MH/SUD.
Stimulant Use Disorder Symptoms12 monthsA self-reported count of Stimulant Use Disorder symptoms, again as captured by the GAIN instrument, measuring past month, past 90 days, year, and lifetime. SUD/MH symptoms as captured by the CAT-MH/SUD.
Patient Reported Outcomes Measurement Information System12 monthsThis scale of person-centered measures includes eight domains (physical function, ability to participate in social roles and activities, anxiety, depression, fatigue, sleep disturbance, cognitive function ability, pain interference, and pain intensity). These are elicited in a five point likert scale (from 1= never to 5 = always) with higher scores equaling more of the concept being measured, which may be better or worse based on the domain measured.
Percent of participants enrolled in Medicaid or private insurance12 monthsDefined as Medicaid or private insurance enrollment during the intervention period.
Re-arrest and Re-incarceration12 monthsArrest or re-incarceration based on any charge using data from Illinois Criminal Justice Information Authority (ICJIA). The investigators will examine the binary outcomes of re-arrest and reincarceration, and also count data models of the number of arrests post-enrollment during days of non-incarceration.
Self-reported rate of illegal activity12 monthsThis is a self-reported count of 19 items across different types of illegal activities following the JCOIN core measures instrument.
Social cost of self reported crime12 monthsTotal social cost of self-reported illegal activity, using estimates for offense-specific economic valuations of social cost per offense and a self-reported count of 19 items across different types of illegal activities.
Social cost of re-arrest and associated offenses12 monthsTotal social cost of crime, using estimates for offense-specific economic valuations of social cost per offense and any charge using data from Illinois Criminal Justice Information Authority (ICJIA).
All-cause mortality12 monthsMortality from any cause
Health services costs12 monthsThis cost measure is based on the self-reported frequency of all healthcare services use. Measured using published Medicare reimbursement rates for all pertinent medical care services. Addiction services cost as measured by DATCAP methodology.

Countries

United States

Contacts

Primary ContactHarold Pollack, PhD
haroldp@uchicago.edu773-834-4292
Backup ContactMai Pho, MD
mpho@bsd.uchicago.edu773-834-3689

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026